Pioneering Medicines: Director, In Vivo Pharmacology - Metabolic Disease

Flagship Pioneering, Inc.•Cambridge, MA

6d•$172,000 - $236,500•Hybrid

About The Position

Pioneering Medicines, Flagship Pioneering’s in-house drug development unit, is dedicated to conceiving and developing a broad portfolio of life-changing treatments for patients built from Flagship’s innovative platforms. Harnessing the drug development expertise of its team together with the power of Flagship's multiple scientific platforms, Pioneering Medicines explores and identifies new product concepts which are then advanced jointly with Flagship’s bioplatform companies. Within Flagship’s Innovation Supply Chain partnerships, Pioneering Medicines works with external collaborators to apply its unique approach to partners’ R&D priorities. These partnerships are highly co-creative strategic alliances that accelerate therapeutic innovation by bringing together partners spanning the full spectrum of drug discovery, development, and production. Pioneering Medicines is seeking a highly motivated and strategic Director of in vivo Pharmacology to support a growing portfolio of assets. This key role will require an individual to direct and oversee in vivo pharmacology efforts, participating in drug discovery and early development activities. The role will involve functional accountability to support assets across a diverse range of modalities using their deep expertise in obesity and metabolic diseases. The candidate will work in cross-functional teams leading and supporting the activities, delivering research leadership, and managing/mentoring junior scientists. The successful candidate is expected to proactively build and maintain strong collaborations with Flagship Pioneering platform companies and large pharma partners. We are seeking individuals who are analytical, goal-oriented, and timeline-sensitive, while maintaining the highest of scientific and ethical standards. Strong communication skills and comfort working in a dynamic and cross-functional team environment are required.

Requirements

PhD + 10 or more years of industry experience or MS with 12+ years of industry experience within in vivo pharmacology or related discipline
Strong understanding of PK/PD assessments in models of disease
Experience in designing ex vivo studies to assess PD and target engagement endpoints, is a must-have.
Proficient experience using rodent metabolic and behavioral cage systems and metabolic phenotyping technologies
In-depth hands-on expertise with in vivo models of obesity and metabolic diseases.
Strong communication skills and comfort working in a dynamic and cross-functional team environment are required.

Nice To Haves

Cardiovascular experience preferred.
Experience and managing in vivo personnel in a dynamic and fast-paced research environment preferred.
Experience working with standard modalities, such as small molecules, antibodies and peptides desired.
Collaborative mindset and a willingness to work with different teams.
Experience with animal facility management, protocol writing, study reports, interactions with IACUC, and use of LIMS.

Responsibilities

Represent the in vivo pharmacology function on drug discovery project teams, supporting assets in obesity and metabolic diseases
Identify and implement in vivo efficacy and PK/PD models to support assessment of lead small molecules, antibodies, peptides and genetic modalities, with a focus on disease-relevant endpoints, PD, and target-specific biomarkers
Participate in partnerships and collaboration efforts with Flagship Platform companies and external pharmaceutical partners
Collaborate closely across functions such as in vitro pharmacology, DMPK/Tox, and translational sciences to advance programs to development candidate and IND-enabling studies
Management of direct report/s to execute internal studies and manage studies at external CROs to achieve program goals
This position is on-site/hybrid in Cambridge, MA and requires hand-on experience and being in the lab
Contribute to discussions with internal project teams, external partners and consultants in developing comprehensive in vivo strategic plans
Work closely with other FSP companies to develop research strategies and evaluate new programs.